Numerous studies revealed that PD-L1 expression is very high in lung cancer, melanoma, glioma, breast cancer and other malignant tumor cells, forming an immunosuppressive tumor microenvironment [5]. The gene discussed is CD274; the disease is central nervous system cancer.